Compound ID | 1919
Synonym(s): BMY-28142
Class: Beta-lactam (cephalosporin, fourth generation)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Binds to bacterial penicillin-binding proteins (PBP) and interferes with bacterial cell wall integrity and synthesis. Active against Gram-negative bacteria but vulnerable to higher levels of extended-spectum beta-lactamases (ESBL) and high resistance rates in Pseudomonas aeruginosa |
| Description: | Semisynthetic Cephalosporine, derived from Cephalosporin C. Fixed combination with several beta-lactamase inhibitors (taniborbactam, zidebactam, enmetazobactam, tazobactam) |
| Year first mentioned: | 1982 |
| Highest developmental phase: | Approved by FDA in 1996 |
| Development status: | Approved |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/5479537 |
| Guide to Pharmacology: | cefepime |
| Citations: |
|